Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hisashi Wada

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Carcinogenesis|May 31, 2015
miR-27 is associated with chemoresistance in esophageal cancer through transformation of normal fibroblasts to cancer-associated fibroblastsKoji Tanaka, Hiroshi Miyata, Keijiro Sugimura, et al.
Cancer Immunity|November 14, 2008
Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicityToshiaki Ishida, Yuichi Obata, Nobuya Ohara, et al.
Molecular Cancer Therapeutics|July 7, 2023
S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T CellsYoji Nagira, Morio Nagira, Ryohei Nagai, et al.
Cancer Immunology, Immunotherapy : CII|March 4, 2008
Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patientKazuhide Tsuji, Toshitada Hamada, Akiko Uenaka, et al.
Journal for Immunotherapy of Cancer|April 3, 2025
Phase I study on neoadjuvant combination immunotherapy with mogamulizumab and nivolumab for solid tumorsKoichi Jinushi, Takuro Saito, Koji Kurose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2015
Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer PatientsKoji Kurose, Yoshihiro Ohue, Hisashi Wada, et al.
Cancer Science|January 26, 2020
Tumor-infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancerKei Yamamoto, Tomoki Makino, Eiichi Sato, et al.
Scientific Reports|March 31, 2022
The impact of CCR8+ regulatory T cells on cytotoxic T cell function in human lung cancerMiya Haruna, Azumi Ueyama, Yoko Yamamoto, et al.
Cancer Immunology, Immunotherapy : CII|August 18, 2020
The impact of ICOS<sup>+</sup> regulatory T cells and Helicobacter pylori infection on the prognosis of patients with gastric and colorectal cancer: potential prognostic benefit of pre-operative eradication therapyShinya Urakawa, Makoto Yamasaki, Tomoki Makino, et al.
Cancer Science|December 5, 2019
Endogenous CXCL9 affects prognosis by regulating tumor-infiltrating natural killer cells in intrahepatic cholangiocarcinomaYasunari Fukuda, Tadafumi Asaoka, Hidetoshi Eguchi, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Carcinogenesis|May 31, 2015
miR-27 is associated with chemoresistance in esophageal cancer through transformation of normal fibroblasts to cancer-associated fibroblastsKoji Tanaka, Hiroshi Miyata, Keijiro Sugimura, et al.
Cancer Immunity|November 14, 2008
Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicityToshiaki Ishida, Yuichi Obata, Nobuya Ohara, et al.
Molecular Cancer Therapeutics|July 7, 2023
S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T CellsYoji Nagira, Morio Nagira, Ryohei Nagai, et al.
Cancer Immunology, Immunotherapy : CII|March 4, 2008
Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patientKazuhide Tsuji, Toshitada Hamada, Akiko Uenaka, et al.
Journal for Immunotherapy of Cancer|April 3, 2025
Phase I study on neoadjuvant combination immunotherapy with mogamulizumab and nivolumab for solid tumorsKoichi Jinushi, Takuro Saito, Koji Kurose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2015
Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer PatientsKoji Kurose, Yoshihiro Ohue, Hisashi Wada, et al.
Cancer Science|January 26, 2020
Tumor-infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancerKei Yamamoto, Tomoki Makino, Eiichi Sato, et al.
Scientific Reports|March 31, 2022
The impact of CCR8+ regulatory T cells on cytotoxic T cell function in human lung cancerMiya Haruna, Azumi Ueyama, Yoko Yamamoto, et al.
Cancer Immunology, Immunotherapy : CII|August 18, 2020
The impact of ICOS<sup>+</sup> regulatory T cells and Helicobacter pylori infection on the prognosis of patients with gastric and colorectal cancer: potential prognostic benefit of pre-operative eradication therapyShinya Urakawa, Makoto Yamasaki, Tomoki Makino, et al.
Cancer Science|December 5, 2019
Endogenous CXCL9 affects prognosis by regulating tumor-infiltrating natural killer cells in intrahepatic cholangiocarcinomaYasunari Fukuda, Tadafumi Asaoka, Hidetoshi Eguchi, et al.
Pageof 10